1.03
Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
0.90%
2.089
|
2.108 | 2.341 | 3.23 | 5.042 |
| Depreciation and Amortization |
38.10%
0.013
|
0.021 | 0.025 | 0.028 | 0.03 |
| Operating Income/Loss |
0.90%
-2.089
|
-2.108 | -2.341 | -3.23 | -5.042 |
| Nonoperating Income/Loss |
24.53%
0.04
|
0.053 | 0.04 | -0.036 | 0.103 |
| Income/Loss From Continuing Operations Before Tax |
0.29%
-2.049
|
-2.055 | -2.301 | -3.266 | -4.939 |
| Income/Loss From Continuing Operations After Tax |
0.29%
-2.049
|
-2.055 | -2.301 | -3.266 | -4.939 |
|
|
0.29%
-2.049
|
-2.055 | -2.301 | -3.266 | -4.939 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
8.03%
10.99
|
10.17 | 10.17 | - | 10.17 |
| Diluted Average Shares |
8.03%
10.99
|
10.17 | 10.17 | - | 10.17 |
| Basic Earnings Per Share |
5.00%
-0.19
|
-0.20 | -0.23 | -0.32 | -0.49 |
| Diluted Earnings Per Share |
5.00%
-0.19
|
-0.20 | -0.23 | -0.32 | -0.49 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):